Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CannaO2
Dallas, Texas, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
CannaO2 commercializes a proprietary, portable canister delivering 95% aviators breathing oxygen infused with 100% organic hemp-derived CBD, aimed at offering rapid, non-smokable cannabinoid and oxygen supplementation; no clinical trial data for drug approval, but marketed for consumer and niche medical use.
- Therapeutic areas
- PulmonologyNeurologyOther
- Modalities
- DeviceCannabinoid (CBD)Oxygen therapy
- Industry
- Therapeutic Medical Devices
02
Partnerships
Haystack Caps (encapsulated CBD technology provider)
Beyond the preview
Go deeper on CannaO2.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CannaO2.